Development of methods to measure humoral immune responses against selected antigens in the common marmoset (Callithrix jacchus) and the effect of pyridostigmine bromide administration

International Immunopharmacology

Volumn 6, Issue 12, 2006, Pages 1755-1764

  Griffiths, Gareth D ^a   Hornby, Rebecca J ^a   Jagger, Christopher P ^b   Brown, Alan P ^b   Stoten, Adam ^b   Pearce, Peter C ^a   Scott, Leah ^a   Pritchard, David I ^b  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Humoral responses; Isotyping reagents; KLH; Marmoset; Non human primate; Pyridostigmine bromide; Vaccines

Indexed keywords

ANTHRAX VACCINE; CHOLERA VACCINE; HEPATITIS B VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; PLAGUE VACCINE; POLIOMYELITIS VACCINE; PYRIDOSTIGMINE; TETANUS TOXOID; YELLOW FEVER VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCHEMISTRY; MARMOSET; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CALLITHRIX; CHOLINESTERASE INHIBITORS; FEMALE; HEMOCYANIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PERSIAN GULF SYNDROME; PYRIDOSTIGMINE BROMIDE; VIRAL VACCINES;

EID: 33749665663     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.08.005     Document Type: Article

References (18)

1. Nash J.E., Fox S.H., Henry B., Hill M.P., Peggs D., et al. Antiparkinsonian actions of ifendopril in the MPTP-lesioned marmoset model of Parkinson's disease. Exp Neurol 165 (2000) 136-142
2. Hille C.J., Fox S.H., Maneuf Y.P., Crossman A.R., and Brotchie J.M. Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease. Exp Neurol 172 (2001) 189-198
3. Henry B., Fox S.H., Crossman A.R., and Brotchie J.M. Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. Exp Neurol 171 (2001) 139-146
4. Neubert R., Helge H., and Neubert D. Thalidomide and the immune system.4. Down-regulation of the CD26 receptor, probably involved in the binding of HIV components to T cells in primates. Life Sci 56 (1994) 407-420
5. Smith D., Trennery P., Farningham D., and Klapwijk J. The selection of marmoset monkeys (Callithrix jacchus) in pharmaceutical toxicology. Lab Anim 35 (2000) 117-130
6. Roberts A.C., Robbins T.W., and Everitt B.J. The effects of intradimensional and extradimensional shifts on visual-discrimination learning in humans and non-human primates. Q J Exp Psychol Sect B-Comp Physiol Psychol 40 (1988) 321-341
7. Pearce P.C., Crofts H.S., Muggleton N.G., Ridout D., and Scott E.A.M. The effects of acutely administered low dose sarin on cognitive behaviour and the electroencephalogram in the common marmoset. J Psychopharmacol 13 (1999) 128-135
8. Crofts H.S., Wilson S., Muggleton N.G., Nutt D.J., Scott E.A.M., and Pearce P.C. Investigation of the sleep electrocorticogram of the common marmoset (Callithrix jacchus) using radiotelemetry. Clin Neurophysiol 112 (2001) 2265-2273
9. Griffiths G.D., Hornby R.J., Stevens D.J., Scott E.A.M., and Upshall D.G. Biological consequences of multiple vaccine and pretreatment in the guinea pig. J Appl Toxicol 21 1 (2001) 59-68
10. Kawashima K., and Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 86 (2000) 29-48
11. + T cells. J Immunol 149 (1992) 3468-3476
12. Ellman G.L., Courtney D., Andres V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7 (1961) 88-95
13. Morton D.B., Abbot D., Barclay R., Close B.S., Ewbank R., et al. Removal of blood from laboratory mammals and birds-first report of the BVA/FRAME/RSPCA/UFAW joint working group on refinement. Lab Anim 27 (1993) 1-22
14. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci US Am 76 (1979) 4350-4354
15. Jones S.M., Griffin K.F., Hodgson I., and Williamson E.D. Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine 21 (2003) 3912-3918
16. Fuji T., and Kawashima K. An independent non-neuronal cholinergic system in lymphocytes. Jpn J Pharmacol 85 (2001) 11-15
17. Telford G., Wilkinson L.J., Hooi D.S.W., Worrall V., Green A.C., et al. An in vitro investigation of the effects of the nerve agent pretreatment pyridostigmine bromide on human peripheral blood T-cell function. Int Immunopharmacol 4 (2004) 1455-1466
18. Griffiths G.D., Telford G., Hooi D.S.W., Cook D.L., Wilkinson L.J., et al. A T-cell-dependent humoral immune response is preserved during the administration of the nerve agent pre-treatment pyridostigmine bromide in a murine model. Int Immunopharmacol 5 (2005) 525-540